BBT Capital Management LLC bought a new stake in Petmed Express Inc (NASDAQ:PETS) in the third quarter, HoldingsChannel reports. The firm bought 26,324 shares of the company’s stock, valued at approximately $869,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Public Employees Retirement Association of Colorado increased its position in Petmed Express by 265.5% during the third quarter. Public Employees Retirement Association of Colorado now owns 3,922 shares of the company’s stock worth $129,000 after purchasing an additional 2,849 shares during the last quarter. Itau Unibanco Holding S.A. acquired a new stake in Petmed Express during the second quarter worth about $154,000. Weatherly Asset Management L. P. acquired a new stake in Petmed Express during the second quarter worth about $205,000. OppenheimerFunds Inc. acquired a new stake in Petmed Express during the second quarter worth about $205,000. Finally, Piedmont Investment Advisors LLC purchased a new position in Petmed Express during the second quarter worth about $211,000. Institutional investors and hedge funds own 95.51% of the company’s stock.

Shares of PETS stock opened at $25.27 on Thursday. The stock has a market cap of $528.63 million, a price-to-earnings ratio of 13.88 and a beta of 0.84. Petmed Express Inc has a 1-year low of $24.81 and a 1-year high of $57.80.

Petmed Express (NASDAQ:PETS) last announced its earnings results on Monday, October 22nd. The company reported $0.52 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.02. The company had revenue of $71.40 million during the quarter, compared to analyst estimates of $71.93 million. Petmed Express had a net margin of 14.88% and a return on equity of 35.53%. Petmed Express’s revenue was up 7.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.43 earnings per share.

The business also recently announced a quarterly dividend, which was paid on Friday, November 16th. Shareholders of record on Monday, November 5th were paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 4.27%. The ex-dividend date was Friday, November 2nd. Petmed Express’s dividend payout ratio (DPR) is presently 59.34%.

In other Petmed Express news, Director Robert C. Schweitzer sold 7,500 shares of the stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $37.00, for a total transaction of $277,500.00. Following the completion of the transaction, the director now owns 88,334 shares of the company’s stock, valued at $3,268,358. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 3.70% of the company’s stock.

PETS has been the subject of several research analyst reports. BidaskClub lowered shares of Petmed Express from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 25th. ValuEngine raised shares of Petmed Express from a “strong sell” rating to a “sell” rating in a research note on Monday, August 20th. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $42.67.

TRADEMARK VIOLATION WARNING: “26,324 Shares in Petmed Express Inc (PETS) Purchased by BBT Capital Management LLC” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at

Petmed Express Company Profile

PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Featured Article: Systematic Risk

Want to see what other hedge funds are holding PETS? Visit to get the latest 13F filings and insider trades for Petmed Express Inc (NASDAQ:PETS).

Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with's FREE daily email newsletter.